STARgraft (10401) Pilot
NCT: NCT07555717 · RECRUITING
Brief Summary
This study is a single site, prospective, single arm evaluation of the safety and effectiveness of the Healionics STARgraft (10401) hemodialysis access graft. The study is enrolling patients with End Stage Renal Disease (ESRD) requiring hemodialysis via a prosthetic vascular graft. The study proposes to evaluate the performance of the investigational STARgraft (10401) compared to the ePTFE controls in a prior study (NCT03916731) and to published results, over a period of 6 months. Additional data out to 36 months post-implantation may be captured.
Frequently Asked Questions
What is STARgraft (10401) Pilot?
STARgraft (10401) Pilot is a clinical trial registered under NCT07555717. Current status: RECRUITING.
What is the status of NCT07555717?
The current status of NCT07555717 (STARgraft (10401) Pilot) is: RECRUITING.
When did STARgraft (10401) Pilot start?
STARgraft (10401) Pilot started on 2026-01-29.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.